Atricure Inc. buy UBS Group AG
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€51.01
Performance (%)
-18.74%
Price
08:05
?
Summary
This prediction is currently active. The prediction for Atricure Inc. disappoints with a performance of -18.74%. This prediction currently runs until 30.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -0.840% | -0.840% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat